Tirzepatide 15mg: what reaching the highest dose actually means

Why the 15mg dose exists and what the trial evidence says

Mounjaro's dosing ladder runs from 2.5mg up through 5, 7.5, 10, 12.5 and finally 15mg. Each step is designed to let the body adjust before more medicine is introduced. The 15mg strength is where the clinical trial results are most striking: in SURMOUNT-1, a 72-week randomised study involving thousands of adults with obesity and no diabetes, participants assigned to tirzepatide peptide 15mg lost approximately 20–21% of their body weight on average. That is a level of weight reduction that was considered near-surgical territory not long ago. The full trial data are published in the New England Journal of Medicine for anyone who wants to read the detail.

The key word in those figures is average. Some participants lost more; some lost less. The 15mg strength does not behave identically for everyone, and its benefit needs to be weighed against how well your body tolerates it. That judgement belongs to your prescriber, not to a comparison website or a dosing chart.

It is also worth knowing that 15mg tirzepatide carries a Black Triangle (▼) designation from the MHRA, which means the medicine is still under additional monitoring. That does not mean it is less safe — it means the regulator wants comprehensive data as real-world use grows. Side effects, including any you consider minor, are worth reporting at the Yellow Card scheme.

The titration path to 15mg: what actually happens

Nobody starts on a 15mg tirzepatide pen. Treatment begins at 2.5mg, a strength chosen specifically to help your digestive system adjust, because the most common side effects (nausea, indigestion, loose stools) tend to be most noticeable in the early weeks and ease with time. After roughly four weeks, the prescriber typically steps the dose upward if tolerance is satisfactory. The full journey from 2.5mg to 15mg spans at least 20 weeks of weekly injections, often longer.

Progress through the tirzepatide dose schedule is not a conveyor belt. If a particular step causes persistent discomfort, your prescriber may hold the dose at that level for an extra month rather than push on. Some people settle at 10mg or 12.5mg because the balance of benefit and side effects is right for them there. There is no clinical failure in stopping short of the maximum. The goal is the weight loss and health benefit, not the highest number on the pen.

One practical habit worth building early: before each injection day, take a moment to check the pen is still refrigerated, undamaged and within date. It takes under a minute and catches the kind of storage issue that could make a dose unreliable. The Patient Information Leaflet inside the box covers the exact temperature window; the 15mg dosage guidance page has further detail on what to look for.

Who tends to reach 15mg, and what the decision turns on

A prescriber considering 15mg tirzepatide will typically look at two things: how much weight loss has occurred on lower doses, and how well the medicine has been tolerated. NICE's appraisal of tirzepatide notes that if a patient achieves less than 5% weight loss after six months at the highest tolerated dose, continuing should be reassessed. That logic works in both directions: if lower doses are working well and being tolerated, there may be a clinical case for reaching the maximum.

Eligibility for tirzepatide in the first place requires a BMI of 30 or above, or 27 or above alongside a weight-related condition such as hypertension, obstructive sleep apnoea or type 2 diabetes. The NICE technology appraisal TA1026 sets the NHS criteria, which are stricter than the licensed criteria for private prescribing. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance, your prescriber takes your full picture into account.

If you are currently on a lower strength and want to understand whether 15mg might be the next step, that conversation starts with your prescribing team. The Mounjaro treatment overview sets out how the medicine works as a whole, and if you want to understand where the titration process began, our tirzepatide 5mg page covers what that earlier dose step involves.

Side effects at 15mg: what changes and what to watch for

The side-effect profile of 15mg tirzepatide is broadly similar to lower doses (gastrointestinal symptoms lead the list) but intensity can increase with dose. Nausea, vomiting, constipation, diarrhoea and reflux are the most commonly reported. These typically peak in the first few days after a dose increase and settle as the body adjusts. Fatigue and headache also appear in trial data.

A few things warrant prompt medical attention regardless of dose. Severe or persistent abdominal pain that spreads toward the back may indicate pancreatitis, get medical help urgently if that happens. Gallbladder problems, significant dehydration from persistent vomiting or diarrhoea, and signs of a serious allergic reaction are also reasons to contact a clinician quickly rather than wait. The NHS tirzepatide medicines page lists these warning signs clearly.

At 15mg specifically, the interaction with oral contraceptives is worth raising with your prescriber if relevant. Tirzepatide can slow gastric emptying enough to affect how the pill is absorbed, particularly in the first weeks after a dose increase. Your prescribing team will talk through what that means for you. You can also find broader support through the nume FAQ page or by reaching out via our contact page.